UNCY - Unicycive Therapeutics GAAP EPS of -$1.20 misses by $0.11
2023-03-31 07:50:07 ET
- Unicycive Therapeutics press release ( NASDAQ: UNCY ): FY GAAP EPS of -$1.20 misses by $0.11 .
- As of December 31, 2022, cash and cash equivalents totaled $0.5 million compared with $16.6 million in cash and cash equivalents held at December 31, 2021.
For further details see:
Unicycive Therapeutics GAAP EPS of -$1.20 misses by $0.11